Cannabis Law Report

DECEMBER 2, 2021

The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

NORML

DECEMBER 6, 2019

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Subjects receiving treatment reported no adverse effects.

Clinical Trials 110

Clinical Trials Patients CBD Therapy 110

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. As previously disclosed, IGC submitted IGC-AD1 to the U.S.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

CannaMD

OCTOBER 14, 2020

A study published earlier this year reveals a simple but interesting pattern: When patients with ADHD consume more cannabis, they require fewer prescription drugs. According to the study’s research team , patients who consume medical marijuana report a “higher occurrence of stopping all ADHD medications.”

Patients 98

Patients Marijuana Cannabinoids Terpenes 98

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Veriheal

SEPTEMBER 16, 2022

Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. This device ensures that patients get metered and precise doses of cannabis. Study Assesses Analgesic Potential of Medical Cannabis for Neuropathy Patients.

Patients 120

Patients Chronic Pain Research and Development Treatment 120

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking. CBD VS. THC.

THC 111

THC CBD Data Cannabinoids 111

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

SEPTEMBER 12, 2021

“I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? or less of THC from the Controlled Substances Act.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Joint Blog

MARCH 2, 2020

According to a new study published in the journal Trauma Surgery & Acute Care , trauma patients who are administered THC capsules consume fewer opioids than do similarly matched control subjects. 66 patients participated in the study: Half received THC, and the other half did not. hours from admission minus 0–48?hours

Patients 47

Patients THC Consumption Data 47

The Joint Blog

MARCH 7, 2021

A new study titled Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial has found that inhaling herbal marijauna is associated with clinical improvements and increased quality of life in patients with mild to moderate ulcerative colitis (UC). The study included 32 patients.

Data 37

Data Patients Treatment THC 37

The Cannigma

NOVEMBER 23, 2021

And for the most part, patients are undertaking this journey alone and often with little guidance. There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. Tell us a bit more about the interview, what did you two talk about?

Data 52

Data Patients Access Wellness and Beauty 52

The Cannigma

JULY 5, 2023

Join a sleep study and help advance real world data Yes, cannabis has an age-old reputation as a sleep aid, but the scientific evidence supporting its use is still shaky, and anecdotal reports are inconclusive. We need more data so consumers can make better decisions – both on an individual level, and as a community at large.

Sleep 52

Sleep THC CBD Blood Pressure 52

Project CBD

JUNE 20, 2023

In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Findings from another recent survey of New York and Minnesota medical cannabis dispensary patients were similar.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

Cannabis Law Report

JUNE 7, 2021

Oliver Bennett, Special Contributor to New Frontier Data. While medical cannabis is legal in many European jurisdictions , patients aiming to travel with it should apply for a permit, and ideally to check in with the destination’s embassy. Back when cannabis was illegal everywhere, travelling with it was a serious act of folly.

Data 91

Data CBD Recreational THC 91

Cannabis Law Report

MARCH 22, 2020

Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. World Health Organization (WHO).

THC 59

THC Clinical Trials Data Consumption 59

SpeedWeed

MARCH 6, 2021

Proposals to cap the amount of THC in cannabis flower and concentrates have been gaining traction in a number of state legislatures, and earlier this week the idea reached the federal level. Most cannabis flower in America’s legal regulated markets ranges between 18% and 23% THC. Forcing patients to purchase more.

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

SEPTEMBER 12, 2022

The Medical Cannabis Advisory Board declined to enact a proposed cap on THC in medical cannabis products. THC – short for tetrahydrocannabinol – is the main psychoactive component in cannabis. Many speakers said 10 percent THC would make medical marijuana ineffective for many patients and only create more problems. “I

THC 52

THC Data Conditions Cannabis 52

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. Different Effects Noted For THC, CBD. An abstract of the research, “No pain, all gain?

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

NORML

NOVEMBER 27, 2019

Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).

Vaping 205

Vaping Oil Data Patients 205

The Joint Blog

OCTOBER 6, 2019

According to a new study published in the journal Pain Management, the presence of THC metabolites in the urine of patients undergoing pain management is associated with lower levels of opioids. … The buprenorphine positive group had the highest percentage of samples containing THC (20.8

Concentrates 48

Concentrates Patients THC Collective 48

NORML

JANUARY 28, 2020

Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.

Marijuana 292

Marijuana Data Decriminalization Policy 292

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

Project CBD

AUGUST 9, 2023

In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal. CBD & THC Cannabidiol (CBD) figured prominently in several noteworthy oral presentations and posters that explored the therapeutic potential of plant cannabinoids from various angles.

Cannabinoids 180

Cannabinoids THC CBD Blood Pressure 180

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). sales last year—a recent study has confirmed that these cannabinoid receptor-binding molecules offer different levels of symptomatic relief for nausea patients. .

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

SEPTEMBER 23, 2021

The FDA and CDC each issued warning notices to the public regarding delta-8 THC products on September 14, 2021, many of which are marketed as hemp products (and include some non-obvious references to other novel cannabinoids that may have similar effects and marketing). Delta-8 THC has psychoactive and intoxicating effects.

THC 52

THC Concentrates Pets DEA 52

SpeedWeed

SEPTEMBER 15, 2021

Vomiting, hallucinations, trouble standing and loss of consciousness are some of the adverse effects associated with consuming hemp-derived products containing delta-8 tetrahydrocannabinol (THC), the U.S. The health effects of delta-8 THC have not yet been researched extensively and are not well-understood,” the CDC stated. “The

THC 52

THC Blood Pressure Concentrates Events 52

The Joint Blog

AUGUST 20, 2020

According to a new study the oral use of synthetic THC is associated with reduced amygdala activation in subjects with post-traumatic stress: Amygdala is “a roughly almond-shaped mass of gray matter inside each cerebral hemisphere, involved with the experiencing of emotions.” Interestingly, low doses of ?9-tetrahydrocannabinol

THC 58

THC Data Cannabinoids Treatment 58

Healer

NOVEMBER 15, 2023

Let’s start by taking a look at the new data and what it means. First, it’s important to point out that I usually wait until new data makes its way through the scientific peer-review process and is published in a journal before giving it much time and energy. During that time, 2,958 (1.9%) developed heart failure.

Data 126

Data Topical Research and Development Conditions 126

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Veriheal

NOVEMBER 18, 2022

According to their announcement , the boxing legends have teamed up to pay homage to their infamous moment with a line of THC and Delta-8 edibles called “Holy Ears.” Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. Will you be buying some Holy Ear edibles? Let us know in the comments!

Edibles 97

Edibles Hemp Epilepsy Programs 97